The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 357-362

  Stankovic, Marija ^a   Nikolic, Aleksandra ^a   Divac, Aleksandra ^a   Tomovic, Andrija ^b   Petrovic Stanojevic, Natasa ^c   Andjelic, Marina ^c   Dopudja Pantic, Vesna ^c   Surlan, Mirjana ^c   Vujicic, Ivan ^c   Ponomarev, Dimitrije ^c   Mitic Milikic, Marija ^d   Kusic, Jelena ^a   Radojkovic, Dragica ^a  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

^d CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SERBIA;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POPULATION GROUPS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SERBIA; SEVERITY OF ILLNESS INDEX;

EID: 50649092671     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0069     Document Type: Article

References (31)

1. Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:269-280.
2. Bombieri C, Giorgi S, Carles S, et al. (2000) A new approach for identifying non-pathogenic mutations: an analysis of the cystic fibrosis transmembrane regulator gene in normal individuals. Hum Genet 106:172-178.
3. Casals T, De-Gracia J, Gallego M, et al. (2004) Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations? Clin Genet 65:490-495.
4. Ciminelli BM, Bonizzato A, Bombieri C, et al. (2007) Highly preferential association of NonF508del CF mutations with the M470 allele. J Cyst Fibros 6:15-22.
5. Cuppens H, Lin W, Jaspers M, et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes: the polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101:487-496.
6. Cuppens H, Marynen P, de Boeck C, Cassiman JJ (1993) Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene. Genomics 18:693-697.
7. Cystic Fibrosis Mutation Database. http://www.genet.sickkids.on.ca/cftr/ app. Accessed on June 5, 2007.
8. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG (2005) Asthma and COPD in cystic fibrosis intron-8 5T carriers: a population-based study. Respir Res 6:113.
9. Divac A, Nikolic A, Mitic-Milikic M, et al. (2004) High frequency of the R75Q CFTR variation in patients with chronic obstructive pulmonary disease. J Cyst Fibros 3:189-191.
10. Dork T, Dworniczak B, Aulehla-Scholz C, et al. (1997) Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 100:365-377.
11. Fanen P, Ghanem N, Vidaud M, et al. (1992) Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics 13:770-776.
12. Friedman KJ, Highsmith WE, Jr., Silverman LM (1991) Detecting multiple cystic fibrosis mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem 37:753-755.
13. Fujiki K, Ishiguro H, Ko SB, et al. (2004) Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. J Med Genet 41:e55.
14. Hoening JM, Heisey DM (2001) The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 55:19-24.
15. Hughes D, Dork T, Stuhrmann M, Graham C (2001) Mutation and haplotype analysis of the CFTR gene in atypically mild cystic fibrosis patients from Northern Ireland. J Med Genet 38:136-139.
16. Jiang Q, Engelhardt JF (1998) Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis. Eur J Hum Genet 6:12-31.
17. Joos L, Pare PD, Sandford AJ (2002) Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly 132:27-37.
18. Kusic J, Radojkovic D, Maletic V, et al. (2002) Mutations and polymorphisms in CFTR genes in infertile men with oligospermia or azoospermia. Srp Arh Celok Lek 130:1-6.
19. Lazaro C, de Cid R, Sunyer J, et al. (1999) Missense mutations in the cystic fibrosis gene in adult patients with asthma. Hum Mutat 14:510-519.
20. Lee JH, Choi JH, Namkung W, et al. (2003) A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet 12:2321-2332.
21. Lenth RV (2006) Java Applets for Power and Sample Size (computer software). http://www.stat.uiowa.edu/~rlenth/Power.
22. Nikolic A, Divac A, Stankovic M, et al. (2006) Analysis of common CFTR polymorphisms 5T, M470V and R75Q in healthy Serbian population. Genetika 42:996-998.
23. Noone PG, Knowles MR (2001) "CFTR-opathies": disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2:328-332.
24. Pilewski JM, Frizzell RA (1999) Role of CFTR in airway disease. Physiol Rev 79:S215-S255.
25. Pompei F, Ciminelli BM, Bombieri C, et al. (2006) Haplotype block structure study of the CFTR gene: most variants are associated with the M470 allele in several European populations. Eur J Hum Genet 14:85-93.
26. Sandford AJ, Weir TD, Pare PD (1997) Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 10:1380-1391.
27. Sharer N, Schwarz M, Malone G, et al. (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339:645-652.
28. Shrimpton AE (2000) R117H and IVS8-5T cystic fibrosis mutation detection by restriction enzyme digestion. Mol Diagn 5:235-238.
29. Tzetis M, Efthymiadou A, Strofalis S, et al. (2001) CFTR gene mutations - including three novel nucleotide substitutions - and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 108:216-221.
30. Walter R, Gottlieb DJ, O'Connor GT (2000) Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ Health Perspect 108:733-742.
31. Wood AM, Stockley RA (2006) The genetics of chronic obstructive pulmonary disease. Respir Res 7:130.